Although IL-6 serum levels were not statistically different between nevi and melanoma patients in our cohort, this preliminary in vitro assay suggests that besides the known HLA-G role, in melanoma, it may influence immune cells in the tumor microenvironment to produce this cytokine. The gene discussed is HLA-G; the disease is neoplasm.